CICLOFOSFAMIDA DR. REDDY'S 1000 mg/2ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ciclofosfamida dr. reddy's 1000 mg/2ml

betapharm arzneimittel gmbh - germania - cyclophosphamidum - conc. pt. sol. inj./perf. - 1000mg/2ml - agenti alchilanti analogi de nitrogen mustard

CICLOFOSFAMIDA DR. REDDY'S 2000 mg/4ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ciclofosfamida dr. reddy's 2000 mg/4ml

betapharm arzneimittel gmbh - germania - cyclophosphamidum - conc. pt. sol. inj./perf. - 2000mg/4ml - agenti alchilanti analogi de nitrogen mustard

CICLOFOSFAMIDA DR. REDDY'S 500 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ciclofosfamida dr. reddy's 500 mg/ml

betapharm arzneimittel gmbh - germania - cyclophosphamidum - conc. pt. sol. inj./perf. - 500mg/ml - agenti alchilanti analogi de nitrogen mustard

Aubagio Uniunea Europeană - română - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomidă - scleroză multiplă - imunosupresoare selective - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Mylan Uniunea Europeană - română - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomidă - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Uniunea Europeană - română - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomidă - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare, imunosupresoare selective - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

BOZILOS 14 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bozilos 14 mg

pharmadox healthcare limited - malta - teriflunomidum - compr. film. - 14mg - imunosupresoare imunosupresoare selective